Études cliniques
Chirurgie mammaire esthétique
Reconstruction mammaire
Give your patients the
GalaFLEX™ Scaffold advantage.
Congès
à venir
Rome, 6–7 novembre, 2025
Masterclass avec le Dr. Buccheri et le Dr. Cagli
Rome, 11–12 novembre, 2025
Masterclass avec le Dr. de Vita
Ratisbonne, 27–28 novembre, 2025
Masterclass avec le Prof. Anker et le Dr. Brebant
Barcelona, 9–10 décembre, 2025
Masterclass avec Dr. Masia
Bruxelles, 6–7 janvier, 2026
Masterclass avec le Pr Hamdi
Brasschaat, 19–20 janvier, 2026
Masterclass avec le Dr Peeters
Paris, 9 février, 2026
Masterclass IGR
Valence,26–27 février, 2026
Masterclass avec le Dr Bistoni
Brasschaat, 23–24 mars 2026
Masterclass avec le Dr Peeters
Tübingen, juin 2026
Masterclass avec le Dr Braun
Londres, 2026
Masterclass avec le Pr. Mallucci
Ratisbonne, 2026
Masterclass avec le Pr. Anker et le Dr. Brebant
Peer insights & Expert interviews
Surgical Procedure Library
This material is intended exclusively for healthcare professionals and is for educational purposes to guide the proper use of GalaFLEX™ Scaffold products.
Surgical Procedure Library
This material is intended exclusively for healthcare professionals and is for educational purposes to guide the proper use of GalaFLEX™ Scaffold products.
Prenez contact avec nous
Références:
1.Williams, Simon F., David P. Martin, and Arikha C. Moses. “The History of GalaFLEX P4HB Scaffold.” Aesthetic Surgery Journal 36.Suppl 2 (2016): S33–S42. PMC. Web. 1 June 2017.
2.Deeken CR, Matthews BD. Characterization of the Mechanical Strength, Resorption Properties, and Histologic Characteristics of a Fully Absorbable Material (Poly-4-hydroxybutyrate-PHASIX Mesh) in a Porcine
Model of Hernia Repair. ISRN Surg. 2013;2013:238067. Published 2013 May 28. doi:10.1155/2013/238067.
3.GalaFLEX™ Scaffold Instructions for Use.
4.Preclinical data on file. Results may not correlate to clinical outcomes.
5.No scaffold is indicated for use in contaminated or infected wounds.
6.Pineda Molina C, Giglio R, Gandhi RM, Sicari BM, Londono R, Hussey GS, et al. Comparison of the host macrophage response to synthetic and biologic surgical meshes used for ventral hernia repair. J Immunol
Regen Med. (2019) 3:13–25.
7.Scott JR, Deeken CR, Martindale RG, Rosen MJ. Evaluation of a fully absorbable poly-4-hydroxybutyrate/absorbable barrier composite mesh in a porcine model of ventral hernia repair. Surg Endosc.
2016;30(9):3691-3701. doi:10.1007/s00464-016-5057-9.
8.Klinge U, Junge K, Spellerberg B, Piroth C, Klosterhalfen B, Schumpelick V. “Do multifilament alloplastic meshes increase the infection rate? Analysis of the polymeric surface, the bacteria adherence, and the in
vivo consequences in a rat model.” J Biomed Mater Res. 2002;63(6):765-71.
9.Halaweish, Ihab, et al. “Novel in vitro model for assessing susceptibility of synthetic hernia repair meshes to Staphylococcus aureus infection using green fluorescent protein-labeled bacteria and modern ima-
ging techniques.” Surgical infections 11.5 (2010): 449-454.
10.Engelsman, A. F., van der Mei, H. C., Ploeg, R. J., & Busscher, H. J. (2007). “The phenomenon of infection with abdominal wall reconstruction.” Biomaterials, 28(14), 2314-2327.
11.Deeken CR, Chen DC, Lopez-Cano M, Martin DP, Badhwar A. Fully resorbable poly-4-hydroxybutyrate (P4HB) mesh for soft tissue repair and reconstruction: A scoping review. Front Surg. 2023;10:1157661. Pu-
blished 2023 Apr 12. doi:10.3389/fsurg.2023.1157661.